Mark Mills

Oct 14, 2024 | radcliffecardiology.com | Michael Gibson |Dipti Itchhaporia |Mark Mills |Peter Calvert

In this episode of the "Innovations in Cardiology" series, host Dr Dipti Itchhaporia, former president of the ACC, is joined by Dr C. Michael Gibson, CEO of the Baim Institute for Research, for an insightful discussion on the latest advancements and future directions in cardiovascular innovation for 2024. Dr Itchhaporia and Dr Gibson explore strategies to enhance efficiency in cardiovascular research, with a focus on direct-to-patient trials.

Jun 25, 2024 | onlinelibrary.wiley.com | Mark Mills |Liverpool John Moores |Liverpool Heart |Peter Calvert

1 INTRODUCTION Femoral access site complications remain the most common adverse event following catheter ablation of atrial fibrillation (AF).1-3 Key factors in reducing these complications include ultrasound-guided access, adequate periprocedural anticoagulation management, and femoral venous hemostasis.4, 5 Until recently, the latter has traditionally been achieved using manual compression.

Feb 26, 2024 | heartrhythmopen.com | Joao Santos |Liverpool Heart |Mark Mills |Peter Calvert

AbstractDefining post-infarct ventricular arrhythmic substrate is challenging with voltage mapping alone, though may be improved in combination with an activation map. Omnipolar Technology on the EnSite X system displays activation as vectors that can be superimposed onto a voltage map. To optimise voltage map settings during ventricular tachycardia (VT) ablation, adjusting them dynamically using Omnipolar vectors. Consecutive patients undergoing substrate mapping were retrospectively studied.